@article{d055ef58e67f484b88c4485669ad5b60,
title = "Clofazimine Drug Susceptibility Testing for Nontuberculous Mycobacteria: A Call to Arms",
author = "Aksamit, {Timothy R.} and Marras, {Theodore K.}",
note = "Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: T. Marras reports grants and personal fees from Insmed, personal fees from AstraZeneca, personal fees from Horizon Therapeutics, personal fees from RedHill Biopharma, personal fees from Novartis, personal fees from Spero Therapeutics, all outside the submitted work. None declared (T. Aksamit).",
year = "2021",
month = jul,
doi = "10.1016/j.chest.2021.02.059",
language = "English (US)",
volume = "160",
pages = "e90",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",
}